This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House
NPS Pharmaceuticals Inc
NPSP : NASDAQ : Health Care
$26.93 | %
Today's Range: 25.56 - 28.49
Avg. Daily Volume: 2,109,000
10/24/14 - 4:00 PM ET

PEER GROUP: Biotechnology

Ticker Company Name Recent
Net Sales
Net Income
NPSP NPS PHARMACEUTICALS INC 26.42 2815.37 1321.00 193.82 66.88
ISIS ISIS PHARMACEUTICALS INC 40.56 4775.33 n/m 151.07 33.77
ICPT INTERCEPT PHARMA INC 216.64 4596.67 n/m 1.66 -4.43
SGEN SEATTLE GENETICS INC 34.73 4287.35 n/m 274.96 12.39
OPK OPKO HEALTH INC 8.31 3566.62 n/m 87.15 4.68
CPHD CEPHEID INC 44.67 3136.19 n/m 451.88 18.77
MYGN MYRIAD GENETICS INC 37.76 2756.40 16.78 778.22 26.91
ACAD ACADIA PHARMACEUTICALS INC 25.29 2514.76 n/m 0.34 -92.92
GEVA SYNAGEVA BIOPHARMA CORP 75.16 2492.68 n/m 8.77 -53.44
AGIO AGIOS PHARMACEUTICALS 64.93 2237.36 n/m 29.83 375.97
EXAS EXACT SCIENCES CORP 23.52 1950.63 n/m 2.37 -42.91
The peer group comparison is based on Major Biotechnology companies of comparable size.

Price Earnings Comparison

NPSP Ind Avg S&P 500
1321.00 79.53 18.06

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV

Latest Stock Upgrades/Downgrades

Top Rated Stocks Top Rated Funds Top Rated ETFs